Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
about
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesisThe hypercoagulable state of malignancy: pathogenesis and current debateMiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1αPlatelet granule secretion continuously prevents intratumor hemorrhage.Extracellular transport of cell-size particles and tumor cells by dendritic cells in culture.Revisiting perioperative chemotherapy: the critical importance of targeting residual cancer prior to wound healingImpact of venous thromboembolism and anticoagulation on cancer and cancer survivalCD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissuesUrinary tissue factor: a potential marker of disease.Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patientsRegulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix moleculesAngiogenesis in epithelian ovarian cancer.Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure.Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals.Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.Napoleone Ferrara and the saga of vascular endothelial growth factor.Haemodynamics in microvascular complications in type 1 diabetes.The effect of therapeutic anticoagulation on overall survival in men receiving first-line docetaxel chemotherapy for metastatic castration-resistant prostate cancer.Role of vascular permeability factor/vascular endothelial growth factor in eye disease.The role of fibrinogen and related fragments in tumour angiogenesis and metastasis.Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells.Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development.The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I-III Breast Cancer Patients Undergoing Surgical Treatment.Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast CancerThe relationship between serum VEGF concentration and prognosis of lung cancerGanoderma lucidum polysaccharides eradicates the blocking effect of fibrinogen on NK cytotoxicity against melanoma cells.Antiangiogenic activity of rPAI-1(23) promotes vasa vasorum regression in hypercholesterolemic mice through a plasmin-dependent mechanismInhibition of tissue factor signaling suppresses tumor growthPersistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasionIdentification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumorsColon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen.Molecular imaging of fibrin in a breast cancer xenograft mouse model.Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stabilityA Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.Influence of Stromal Components on Lung Cancer Carcinogenesis.Elevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of Western patients undergoing surgery for colorectal cancer.Cross-talk of integrin alpha3beta1 and tissue factor in cell migration.Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment
P2860
Q24684263-8BB04B41-EC42-494C-837F-0ADB90A8768CQ28212265-0FB2B6C4-60CD-4508-A95A-00CA74FBA240Q28542821-2430462B-39D8-459B-AABA-6DADC51A0AC4Q30483704-40CB48D9-2291-4B96-8632-851EC4ADA2A9Q30574017-EBFA6B40-081C-4FE5-A791-0C87DBD91264Q33433283-CE68DF72-DAFD-4FEC-B409-2D4E46D6B16FQ33561203-B90FE5B1-56FE-49AA-961F-21A4D25C07F9Q33615216-7A0BD1C4-505C-4A4F-AC28-86EA21E6080AQ33682793-B943946B-9EC0-49F0-A731-A7B869680F3BQ33858614-66B32E37-BEDF-4607-AE5D-C9A3D5FA5FFAQ33904614-BE07BC93-902A-4FDA-9234-CCF6F3618C80Q33919078-89E41A08-9618-4C06-ACDA-F77AADC6B39BQ34103169-E02F379F-87D6-4B54-83D2-18312154DAF6Q34442820-2D37C998-2947-40A6-813D-374F7814338AQ34548428-877A34D9-34D9-44FC-AB38-634A714D00F3Q34733316-55BBE95B-3DD1-4A9F-A5C8-3CCB8C18CF30Q34774005-EDD20367-DCD8-4A39-8587-E2BFB227D7B7Q34787946-14D24D11-F752-44BE-BC45-D228D8E3E7ACQ34804249-CBD06250-6689-41E3-9349-47386D7FB2F6Q35095964-35196227-E393-4371-8E7B-48C15930D9EBQ35300661-1EF35B62-6488-4E9A-892A-F26135011074Q35547277-BE41BF5A-4109-4DB5-A6B5-0B40799282BBQ35774026-04763AC9-19C8-4EB0-9D80-F5427B1AB8D1Q35797898-3BDC8B39-1E92-407F-8056-5F627265207FQ35850665-595C483F-A9CD-468B-BD6D-C2B413914604Q35901137-00675541-05AC-440A-81B3-7FAFACE586B3Q35937223-7F57759C-AB73-402C-A241-442C7C28F24DQ35995996-A6217C8E-7B7D-41F2-9FD1-CC4669EE1972Q36018465-3B9B2AA0-F2C9-48C3-B9F6-3BC7CD986CEDQ36384586-76B30BF1-E5B3-4A01-BB30-5FB0373EE0C1Q36420521-512DA3AB-DDA6-4F03-B8A0-2F7E8750E90AQ36699353-1C1E81B9-F105-4F73-B8BF-ACFA92A4F572Q36732743-C38CB245-5814-4F80-905C-0A459A38B97FQ36843006-6314A829-B1C7-476C-B9FE-CF66413B20C8Q36857442-948EB0AD-8A9F-478D-933E-83045FBC2D7FQ37091111-1578C61E-61BA-4778-B51E-B2758F2C3CFAQ37281312-658E5A2B-B056-45A0-B786-1E22F93B85C6Q37483472-75972393-2278-488E-87F1-2E1BDF2ED1C7Q37537928-7D15B18F-3F59-41BD-8923-C7E9BD7F6D48Q37624146-A94B78D6-CD8F-424D-8CC7-02DEC7E3AC7A
P2860
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
description
1992 nî lūn-bûn
@nan
1992 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
@ast
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
@en
type
label
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
@ast
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
@en
prefLabel
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
@ast
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
@en
P2093
P2860
P1476
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
@en
P2093
Sioussat TM
van de Water L
P2860
P304
P356
10.1111/J.1749-6632.1992.TB51603.X
P407
P577
1992-12-01T00:00:00Z